NCT01865370 Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects Status COMPLETED Phase PHASE2/PHASE3
NCT01858376 Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans Status COMPLETED Phase NA
NCT01845428 Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome Status COMPLETED Phase PHASE1
NCT01842256 Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. Status COMPLETED Phase PHASE1
NCT01842230 Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine Status COMPLETED Phase PHASE1
NCT01806324 A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01764178 To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet Status COMPLETED Phase PHASE1
NCT01763918 Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 Status COMPLETED Phase PHASE3
NCT01763905 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 Status COMPLETED Phase PHASE3
NCT01763866 LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 Status COMPLETED Phase PHASE3
NCT01763827 Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 Status COMPLETED Phase PHASE3
NCT01735149 Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids Status UNKNOWN Phase PHASE2/PHASE3